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This study presents a ‘value of life’ estimate for children 
in Metro Manila of between US$0.70 million and 
US$0.80 million. It was carried out by Rosalina Palanca-
Tan, from the Department of Economics at the Ateneo 
de Manila University in Quezon City.  
 
Palanca-Tan’s assessment is based on parents’ 
willingness to pay for two hypothetical dengue vaccines 
for their children. It takes an innovative approach to the 
valuation challenge, one that removes much of the 
uncertainty surrounding similar past studies. This 
method involves isolating people’s willingness to pay 
for the reduction in mortality risk that the vaccines 
bring. This is done by disentangling it from their 
willingness to pay for other related benefits that the 
vaccines bring (such as reducing the pain associated 
with illness).  
 
The study succeeds in producing a result that can be 
used generally to value life in a range of scenarios and 
situations. As children are most vulnerable to 
environmental degradation such as air pollution and 
water pollution, this valuation will be particularly useful 
to environmental policy makers and campaigners 
looking to estimate the overall benefit of their work. 
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 VALUE OF STATISTICAL LIFE ESTIMATES FOR CHILDREN IN METRO 






Based on parents’ stated willingness to pay (WTP) for dengue vaccines for their 
children, this paper arrived at estimates of the value of statistical life (VSL) of children 
in Metro Manila. Unlike in previous VSL studies, respondents in this study were tasked 
(through a play-like activity) to isolate the value they attached to the specified mortality 
risk reduction from the stated WTP for the risk intervention scenario, i.e., a dengue 
vaccine. This was done to remove the influence of the risk context in the VSL estimate 
and hence improve the estimate’s usefulness and applicability in a variety of  
environment-related project and policy assessments. The results of the two-stage 
estimation procedure consisting of a household vaccine demand model and a random 
effects probit model of the vaccine purchase decision for individual members 
conformed with economic intuition (household vaccine demand increased significantly 
increased with higher income while willingness to pay significantly increased with 
lower prices) and yielded value of statistical life estimates for children in Metro Manila 
in the range of US$0.70-0.80 million. 
 
1.0 INTRODUCTION  
One major benefit justifying environmental policies is the reduction in people’s 
risk of death. In developing countries like the Philippines, however, this important 
benefit is commonly excluded or not properly imputed in environmental cost-benefit 
analyses and other types of environmental project assessments due to the dearth of 
studies on the value of mortality risk reduction and concern over the applicability of 
values derived in developed countries (benefit transfer). This exclusion may result in 
underestimated benefits that could cause the defeat of many environmental policy 
initiatives. This paper presents estimates of the value of statistical life (VSL) of a child 
in Metro Manila based on parents’ willingness to pay (WTP) for dengue vaccines for 
(their) children1—the population segment most vulnerable to environmental degradation 
such as air pollution and water pollution.   
                                                 
1 This approach is in line with the “parental sovereignty” perspective on children’s welfare which 
advocates parental altruism and parental guardianship or stewardship. It is an alternative to the consumer 
sovereignty normative perspective-based “children’s sovereignty” which assumes that each individual has 
well-defined preferences and is the best judge of his or her own welfare.  Freeman (2003, p. 340) writes: 
“The children’s sovereignty perspective is not ethically attractive. Children are immature and lack the 
cognitive ability to make choices about health and safety. They may not have well-defined preferences 
over the full range of alternatives necessary to make reasoned choices. Also, they do not control the 







This study used a specific intervention scenario, i.e., a dengue vaccine, to avoid 
the highly hypothetical nature of a general type of intervention that reduces mortality 
risk from different causes (see, for instance, Krupnick et al 2002; Alberini, Hunt and 
Markandya 2004; Mahmud 2005; Maskery et al 2007). A multi-purpose intervention 
can be expected to generate a high incidence of scenario rejection in the Philippine 
setting where the market is already flooded with health products promising remedies for 
all problems and the consuming public have grown highly skeptical about such 
products. A dengue vaccine was chosen as it offered a highly familiar risk and 
intervention context for the respondents of this study. Dengue outbreaks in the 
Philippines in the last two decades have victimized people across all income classes and 
increased their awareness of the risk of death from dengue, particularly among children. 
Vaccination is also widely accepted in the country as an effective means of preventing 
diseases in children, and news about positive developments in dengue vaccine research 
have appeared in Philippine newspapers since 2005.  A dengue vaccine would also be a 
private good which is not likely to result in substantial “warm glow effects” as the virus 
is not transmitted directly from person to person.  
Stated WTP for a dengue vaccine would include not only WTP for the 
elimination of the risk of dying from dengue, but also WTP for reduced morbidity  
effects (avoidance of suffering, pain, inconvenience and loss of income experienced by 
the sick person and his/her caregivers) and savings on other preventive measures 
(Cropper et al 2004). This is inherent in a specific intervention VSL scenario where 
respondents are inclined to consider effects other than the reduction in the risk of dying. 
This also relates to the issue of VSL estimates being context-specific. The non-mortality 
risk component of WTP for a specific intervention is expectedly context-specific. The 
goal of most VSL studies, however, is to come up with estimates that can be applied in 
the assessment of a variety of environmental projects and policies. What existing studies 
have done so far is to look at how WTP is affected by different risk characteristics such 
as degree of dread, severity, voluntariness, controllability, personal exposure and 
perceived immediate occurrence, and to compare VSL estimates in different contexts to 
arrive at some adjustment ratios (Hammitt and Liu 2004; Vassandumrongdee and 
Matsuoka 2005; Revesz 1999).  This study undertook a strategy that had not been done 
in previous VSL research. We broke down the stated WTP into the different benefits 
that could be derived from the dengue vaccine by allocating the WTP amount into five 
benefits, one of which was mortality risk reduction. In a game-like manner that also 
served to break the monotony of the question-answer sequence of the questionnaire, 
respondents were given ten tokens and five containers, each labeled with one reason for 
buying the vaccine. The respondents were asked to think of the ten tokens as 
representing their WTP for the vaccine and to divide them into the five given 
reasons/benefits. Only the WTP for the mortality risk reduction was used in the 
calculation of the VSL.  To our knowledge, no VSL study has isolated the WTP for 
mortality risk reduction from the WTP stated by the repondent before the VSL was 
calculated. 
This study also differs from existing VSL literature in that it elicited the WTP 
for a dengue vaccine for each and every member of the household and used the WTP 
decisions for all household members in the VSL calculation. Previous VSL studies 
elicited the WTP for mortality risk reduction for only one household member. For 
example, Cropper et al (2004) elicited the household head’s WTP for a malaria vaccine 
for himself/herself and Maskery et al (2007) elicited the survey respondent’s WTP for a 







see that eliciting WTP for a particular household member, say the youngest child, can 
result in biased estimates. We also believe that our approach better reflects the reality of 
household decision-making wherein the head decides to purchase an individually 
consumed good for one or several members after considering the needs and wants of all 
members in relation to the household budget. It is not always clear that this is the case 
when a respondent is asked to focus on just one household member. 
As the study deviated from the conventional single VSL-WTP question per 
respondent structure, we also had to employ a different modeling procedure. This is the 
third unique feature of the study. We used a two-stage regression model where the 
household vaccine demand in proportion to household size was regressed with 
household income and a vector of respondent and other household characteristics in the 
first stage, and the “yes-no” response to the dichotomous choice WTP question for each 
household member was specified as a random effects probit function of the predicted 
household vaccine demand (derived in the first stage) and a vector of particular 
household member characteristics in the second stage.  
The results from our two-stage regression model conformed with economic 
theory – vaccine demand (as a proportion of household size) specification exhibited a 
significant positive income effect while the individual vaccine purchase decisions 
exhibited a significant negative price effect. The signs of the other explanatory variables 
in the model were generally in accord with intuition. The VSL estimates for children in 
Metro Manila ranged from US$0.70-0.80 million, an order of magnitude comparable 
with VSL estimates in existing literature. 
 
2.0 METHODOLOGY 
2.1 Survey Instrument Development 
The final form of the survey instrument was the result of a series of key 
informant interviews (KIIs) with doctors and medical professionals  specializing in 
dengue, infectious diseases and pediatrics; focus group discussions (FGDs) with 
different types of respondents from low- to high-income households; and questionnaire 
pre-tests. These pre-survey activities provided important inputs in the formulation of the 
contingent valuation (CV) scenarios and range of bid levels as well as in coming up 
with appropriate visual aids and phrasing of questions.  
Two CV scenarios were constructed: (1) a dengue vaccine that provided 
protection for one year and (2) a dengue vaccine that provided protection for ten years. 
During this study, potential dengue vaccines were still being developed and there were 
yet no clear indications of the definite forms the dengue vaccine would take. 
Considering the need to make the valuation task manageable for all kinds of 
respondents, both the one-year and ten-year duration vaccines were presented in the CV 
scenarios as a one-dose vaccine that could be purchased at hospitals, doctors’ clinics 
and drug stores, and could be administered either as an injection or oral drops. Five bid 
levels (dengue vaccine prices) were used for both one-year and ten-year duration 






(PhP 3,000) and US$ 100 (PhP 5,000).2 The target sample size of 500 respondents 
consisted of split samples of 50 respondents for each bid price and vaccine duration.  
The survey instrument comprised four parts: A, B, C and D. Part A included a 
brief introduction on the purpose of the survey as well as easy-to-answer questions 
about the respondent and his/her household. Questions to assess the level of awareness 
of the respondent about dengue and preventive measures undertaken by the 
respondent’s household were also posed. Furthermore, Part A drew cost-of-illness data 
from those households with experience of dengue.  
Part B was a short training module on understanding mortality risk reduction. 
This module included information on mortality risks associated with leading causes of 
death in the Philippines. Apart from familiarizing respondents with the concept of 
mortality risk reduction, the information provided a basis of comparison  for the 
mortality risk reduction from the dengue vaccine. Preferred over the risk scale by the 
less educated and lower income FGD and pre-test participants, risk grids were used as 
visual aids in the survey.  A question to test for comprehension was asked at the end of 
the explanation. The enumerator was instructed to note down the number of times the 
explanation was repeated before the respondent was able to give the correct answer. 
Part C introduced the CV scenario by presenting information details on dengue 
(e.g., the four dengue virus serotypes, modes of infection, incidence, medication and 
prevention), the difference between mortality risks  from dengue of the 14 years and 
below age group (1/100,000) and the 15 years and above age group (1/1,000,000) 
likewise using risk grids as visual aids, and recent developments in dengue vaccine 
research. The WTP question, following the dichotomous choice formulation, was 
structured in the following way: the respondent was first asked how many vaccines 
he/she would buy for his/her household members at the stated price, after which he/she 
was asked who in the household would be given the vaccine. A short “cheap talk” script  
reminding respondents to consider their budget constraints and to answer in accordance 
with what they would really do if the vaccine were already available in the market was 
inserted in the WTP question. Part C also included two sets of debriefing questions. One 
set, addressed to respondents who would buy the vaccine, consisted of three items:              
(1) the degree of certainty of buying the vaccine, (2) the expenditure item that would be 
reduced most in order to buy the vaccine, and (3) the relative importance of the different 
reasons for buying the vaccine for each  of the two age groups. Respondents not buying 
the vaccine, on the other hand, were first asked if they would take the vaccine for any 
household members if it were offered for free. A “no” response to this question was 
followed by a question as to the reasons why they would not want the vaccine even if it 
were free.  
Finally, Part D solicited additional socio-economic and health information. 
These questions were asked last to avoid generating respondents’ disinterest early on in 
the survey. At the end of the interview, the enumerator recorded his/her assessment of 
the quality of the interview. 
                                                 







2.2 Sampling and Data Collection 
The survey was conducted in Metropolitan Manila (MM). MM, one of 17 
regions in the Philippines, is the National Capital Region (NCR) and the political, 
economic, social and cultural center of the Philippines. It is one of the more modern 
metropolises in Southeast Asia and is among the world’s 30 most populous. Covering 
an area of only 636 km2 (square kilometers), MM is the smallest of the 17 regions but it 
is the most populous (11.3 million in 2005, 13% of the entire Philippine population) and 
the most densely populated (17,751 per km2). Three other regions in the Philippines that 
include metropolitan areas like the cities of MM are Central Luzon, Central Visayas and 
Northern Mindanao. The capital and central cities in these regions are highly urbanized 
as in MM. Metro Cebu, the counterpart of MM in Central Visayas, includes cities where 
the population density reaches 10,000 per km2.   The most densely populated cities in 
Central Luzon—Angeles City (4,378 per km2),  and in Northern Mindanao—Cagayan 
de Oro City (1,119 per km2), on the other hand, are much less dense. In terms of the 
average number of reported dengue cases per year from 2000-2005, these four regions 
occupy the top four places: Metro Manila (3,738), Central Luzon (2,595), Central 
Visayas (2,070), and Northern Mindanao (2,057).  
MM consists of 14 cities and three municipalities. Respondents were drawn 
from the five largest cities in MM namely, Quezon City (accounting for 21% of the MM 
population), Manila (15%), Caloocan (11%), Makati (5%), and Pasig (5%).3  There 
have been a greater incidence of dengue and more cases of death from it in Quezon City 
compared to the other four cities.  In 2000, for instance, there were 38 reported deaths 
from dengue in Quezon City which was equivalent to a mortality rate of 1.8 per 
100,000—a figure substantially higher than MM’s 1.1 and the national rate of 0.5. The 
mortality rates from dengue in the same year for the other four sampled cities were as 
follows: 1.3 for Caloocan, 1.1 for Pasig, 1.0 for Makati and 0.8 for Manila.  
A sample of 100 respondents was taken from each of the five cities. For each 
city, a residential barangay4, with residents belonging to all social classes, was 
randomly selected. Respondents were chosen using systematic sampling. Permission 
and assistance to conduct the survey were secured from the barangay captain’s office.  
With maps provided by the barangay office, starting points were identified and 
enumerators were instructed to approach the 50th house from a starting point. In case of 
refusal to participate, the next house would be approached. Every succeeding 
respondent approached had to be the 50th house from the last responding household. 
Each respondent was randomly assigned a vaccine duration and price. 
The survey was conducted through in-person interviews from the months of 
February to May 2007. Enumerators, recruited from a pool of applicants who were at 
least university students, were given a two-day training course prior to the pre-tests 
following the guidelines in Whittington (1996, 2002). The first day of training 
comprised an overview of the objectives of the study and the contingent valuation 
                                                 
3 The other nine cities and three municipalities and their populations are: Las Pinas (4.6% of the MM 
population), Malabon (3.8%), Mandaluyong (2.7%), Marikina (3.8%), Munitnglupa (3.7%), Navotas 
(2.2%), Paranaque (4.8%), Pasay (3.4%), Pateros (0.6%), San Juan (4.3%), Taguig (4.5%) and 
Valenzuela (4.7%). Population shares were computed based on 2000 census data. 






approach as well as information on dengue and vaccines. On the second day, 
enumerators were trained on the survey instrument, with the meaning and the reasons 
for each question and statement in the questionnaire discussed. The training included 
role-playing exercises.  
 
2.3 Data Analysis 
2.3.1 WTP for a dengue vaccine 
A two-stage estimation procedure was undertaken to arrive at the mean 
willingness to pay for a dengue vaccine for young members of the household aged 14 
years and below. In the first stage, household demand for dengue vaccines d (expressed 
in terms of the number of vaccines to be purchased in proportion to the number of 
household members) was specified as a linear function of the vectors of the 
respondent’s characteristics r, household characteristics z (excluding income), and 
household income y: 
d = d(r, z, y)        (1) 
The predicted household vaccine demand derived in the first stage was then 
included as an explanatory variable in the vaccine purchase decisions for individual 
household members in the second stage. This captured the interdependence of the 
budget constraint in the individual vaccine purchase decisions for all household 
members.  
In stage 2, we analyzed the “yes-no” response to the dichotomous choice CV 
question using the framework developed by Hanemann (1984) based on the random 
utility model which is briefly discussed below.   
Indirect utility, u, depends on h (which takes on the value 1 if the respondent is 
buying the vaccine for a household member, 0 if otherwise), household income y, a 
vector of household member characteristics m, a vector of respondent and his/her 
household’s characteristics z, and a component of preferences that are known only to the 
respondent and not to the researcher h.. This utility function is specified as additively 
separable in deterministic (v) and stochastic preferences (): 
u(h, y, m, z,  h) = v(h, y, m, z) + h     (2)  
As the random part of preference is unknown, only probability statements about 
“yes” and “no” responses can be made. The probability that a bid price B for the vaccine 
is accepted can be expressed as: 
Pr (yes) = Pr [v(1, y-B, m, z) + 1 ≥  v(0, y, m, z) + 0] 
   = Pr [v(1, y-B, m, z) - v(0, y, m, z) ≥ 0 - 1 ]  (3) 








F (∆v), the probability that the random variable  will be less than ∆v, 
represents the cumulative density function of the respondent’s true maximum 
willingness to pay. 
We assumed that the stochastic terms   are independently and identically 
distributed following a normal distribution with a mean of 0 and a standard deviation of 
σ, and used the probit regression procedure to evaluate (3). For the indirect utility 
specification, we assumed a linear function such that income would disappear in the 
change in utility term in (3). The parameter estimates from the binary probit model were 
used to calculate the mean willingness to pay E(B) according to the following equation: 
E(B) = - (/σ)X/(B/σ) = - X/B     (4) 
 is a vector of the estimated coefficients of all explanatory variables except 
price  (vector X) and B is the estimate for the price coefficient.  
Each child member of the household aged 14 years and below for whom the 
respondent decided to buy or not to buy a vaccine constituted one observation (one data 
point) in the binary choice data set.  Hence, each household (that is, one filled-up 
questionnaire) contributed a number of data points/observations equivalent to the 
number of household members aged 14 years and below. Household member 
characteristics used as explanatory variables were age, gender and whether the 
household member was the respondent’s own child (this last characteristic was 
represented by a dummy variable). As respondent and household characteristics were 
already incorporated in the household vaccine demand model, only the predicted 
vaccine demand variable in proportion to the household size was used in the individual 
choice decision model. Finally, the probit regression procedure was run as an 
unbalanced panel random effects model to capture the interdependence of the decisions 
to buy the vaccine for members in each household. 
The non-parametric mean willingness to pay for a dengue vaccine and its 
variance were calculated using the lower bound Turnbull formula (Haab and McConnell 
2003):  
               M 
ELB(B) = ∑ Bj (Fj+1 ‐ Fj)            (5)   
              j=0 
           M 
V(ELB(B)) = ∑ (Fj (1 ‐ Fj ) ( Bj ‐ Bj‐1)2/ Tj)        (6)   
          j=1 
M is the number of bids; B  is the bid level; Tj is the number of respondents 
offered the bid price Bj; Fj is the proportion of “no” responses to the bid price Bj; F0=0 






2.3.2 Isolating the willingness to pay for mortality risk reduction 
Stated willingness to pay for a dengue vaccine includes not only the value 
attached to the mortality risk reduction effect of the vaccine, but also to the other 
benefits that can be derived from the vaccine such as avoidance of pain and suffering, 
savings on medical and related expenses, and avoidance of lost household income.  The 
relative importance of a mortality risk reduction effect vis-à-vis the other effects 
depends on the nature of the disease or the cause of death. The willingness to pay for a 
reduction in the risk of death from dengue, for instance, would be different in the case 
of traffic accidents, cancer and other diseases with varying durations and intensites of 
pain and suffering. A number of studies has shown that the willingness to pay for 
mortality risk reduction, and hence the resulting VSL estimate, was context-specific. 
Hammitt and Liu (2004) found that the willingness to pay for mortality risk reduction 
varied according to disease type and latency, the affected body organ, environmental 
pathway, and payment mechanism. Jones-Lee, Hammerton and Philips (1985) arrived at 
a VSL estimate based on motor vehicle crashes (£23 million) that was higher than those 
based on heart disease (£13 million) and cancer (£7 million). 
The goal of most VSL studies is to come up with estimates that can be applied 
in the assessment of a variety of public projects and policies (e.g., in transport, health 
and the environment). VSL estimates based on a particular risk context are applied to 
other risk contexts commonly through the use of adjustment factors. Revesz (1999), for 
instance, proposed to adjust the standard VSL used by the U.S. Environmental 
Protection Agency in a carcinogenic pollutants emission control project by a factor of 
two for risk characterized by involuntariness and uncontrollability, and by a factor of 
four in the case of risks characterized by dread. Some researchers and policy-makers, 
however, are skeptical about the derivation and use of such adjustment factors. For 
example, due to lack of empirical VSL studies in the air pollution context and reliable 
information to support the adjustment of the road safety-based VSL for air pollution in 
the United Kingdom, its Department of Health has refrained from quantifying health 
benefits of air pollution reduction in monetary terms (Dunn 2001). 
This paper presents an alternative method of arriving at a VSL estimate with the 
influence of the risk context removed. This study opted to isolate the willingness to pay 
for the reduction in mortality risk by soliciting such information directly from the 
respondents.  Respondents were asked to break down the amount they were willing to 
pay for a dengue vaccine into the different benefits that could be derived from the 
vaccine. Specifically, they were tasked to state the level of importance they accorded to 
the following five reasons for buying the dengue vaccine: (1) to prevent death, (2) to 
avoid the pain and suffering from being ill with dengue, (3) to avoid incurring medical 
expenses, (4) to avoid inconvenience and absenteeism from work or school, and (5) to 
avoid having to undertake and spend on other precautionary measures. Our FGDs 
revealed that respondents would have difficulty allocating a total weight of 100 
(percent) or even 10 (point system) among the five reasons without any computation 
aid. So we came up with a game-like activity in which respondents were given ten 
tokens and five containers. The respondents were told to think of the ten tokens as 
representing the amount they would pay for the vaccine and to divide them into the five 







The average weight given to the mortality risk reduction by respondents buying 
the dengue vaccine, w, was used to isolate the willingness to pay for the mortality 
reduction, WTP, from the mean willingness to pay for the dengue vaccine, E(B):  
WTP = w E(B)       (7) 
 
2.3.3 VSL 
VSL is the value an individual attaches to a reduction in mortality risk. 
Technically, it is the rate at which the individual would trade money for a small change 
in the probability of dying, ∆r, during a specified time period (Hammitt and Graham 
1999): 
 VSL = WTP/∆r      (8) 
In the case of the ten-year duration vaccine for which payment would be made 
only once in the first year,  discounting of the mortality risk reduction, which would be 
realized  over a period of ten years, was undertaken. Viscusi, Hakes and Carlin (1997) 
pointed out that insufficient accounting for discounting and time lags before the risk of 
death appears could overstate people’s perception of risks.  For this study, we used a 5% 
discount rate (Hammar and Johansson-Stenman 2004). This positive discount factor 
would effect an upward adjustment in the value of the mortality risk reduction from the 
ten-year duration vaccine.  
 
3.0 RESULTS AND DISCUSSION 
3.1 Respondent and Household Characteristics 
3.1.1 Socio-economic profile 
The first three panels of Table 1 give the household level descriptive statistics 
used in the vaccine demand model while the last panel presents the individual 
characteristics of household members aged 14 years and below that were used in the 
binary probit vaccine purchase decision model.  
The socio-economic profile of the respondents and their households is given in 
the first two panels of the table. About a fifth of the respondents were male and about a 
third were smokers. The respondents, on average, were 34 years old. The average 
household in our sample had five members and a monthly income of US$492-501 (PhP 
24,590-25,060). These figures compare well with household statistics in the 2003 
National Demographic and Health Survey of the Philippines (NSO 2004) which 
reported an average household size of 4.69 persons and a mean monthly household 









Table 1. Descriptive statistics 










RespondentGender =1 if male, 0 if female 0.24 0.43 0.18 0.38
RespondentAge Years 34.07 6.99 33.49 7.12
Respondent 
Smoking 
=1 if smoking, 0 otherwise .34 0.47 0.28 0.45
Household (HH) characteristics 
HHSize Number of all household 
members 
5.10 1.52 5.14 1.46
Income Monthly HH income         US$ 









Pasig Survey site dummy 0.20 0.40 0.20 0.40
Manila Survey site dummy 0.20 0.40 0.20 0.40
Caloocan Survey site dummy 0.20 0.40 0.20 0.40
Makati Survey site dummy 0.20 0.40 0.20 0.40
Dengue-related variables 
DengueFamily =1 if HH with dengue case/s,    
0 otherwise 
0.07 0.25 0.07 0.25
DengueOthers =1 if respondent knew 
someone who had dengue,         
0 otherwise 
0.63 0.48 0.59 0.49
Correct No. of correct answers to 
dengue information questions 
6.17 1.14 6.01 1.24
Prevent No. of dengue preventive 
methods practiced by HH 
4.41 1.29 4.33 1.26
FeverFrequency Frequency of fever in the HH 
=1 if frequent, 2 if not so 
frequent, 3 if sometimes,            
4 if rarely 
3.30 0.67 3.27 0.72
Individual household member characteristics (14 years old & below) 
MemberGender =1 if male, 0 if female 0.50 0.50 0.46 0.50
MemberAge Years 7.49 4.37 7.50 4.26
RespondentChild =1 if member is respondent’s 
own child, 0 otherwise 








3.1.2 Dengue exposure, knowledge and preventive practices 
The third panel of Table 1 summarizes the data gathered on dengue-related 
variables. Although the majority of the respondents personally knew someone who had 
been ill with dengue, only about 32 respondents reported cases of dengue in their 
households, 29 of which had one case while the remaining three had 2 cases.5  
The survey results reflected a relatively high although not perfect knowledge 
about dengue.  Of the eight dengue information questions, each respondent, on average, 
answered six correctly. The first panel of Table 2 indicates the respondents’ knowledge 
about the different aspects of dengue.  Almost all were aware about the particular insect 
(mosquito) that caused dengue, but there was less familiarity with the particular 
characteristics of the mosquito that carried the virus (that it bites during the daytime and 
lays its eggs in clean waters). Alarmingly, about half of the respondents wrongly 
thought that the dengue mosquito laid and bred its eggs only in dirty water. There was 
also some degree of misconception about the conditions (transmission and immunity) 
and treatment (blood transfusion) of dengue victims. The lowest proportion of correct 
answers was found for item 8. It appears that the majority of  the respondents were yet 
not adequately informed of all the ways by which to prevent dengue. 
In regard to dengue preventive methods, households, on average, practiced four 
out of the seven methods cited. The second panel of Table 2 shows particular dengue 
preventive methods practiced by households. Almost all households were doing the 
relatively easier tasks of regularly cleaning and covering (if possible) water containers. 
The majority of the respondents limited outside play of children during the rainy season 
while only about half practiced the more difficult task (especially for houses with more 
than one floor) of cleaning roof gutters and the more costly method of using  insect 
repellant lotion. While 56% of the households used mosquito-killing chemicals, only 








                                                 
5 The survey instrument included cost-of-illness questions for households with dengue cases. All except 
for three gave some rough estimates of the total medical costs (medicine, doctor’s fee, laboratory and 
hospital fees)  incurred, but as it was admittedly difficult for most respondents to recall the expenses, we 
had to be very cautious in using the data. The costs for five undated cases ranged from US$20                   
(PhP 1,000) to US$200 (PhP 10,000). The costs for the majority of the cases (14 out of 24), occurring 
between 2002 and 2007, ranged from US$200 (PhP 10,000) to US$400 (PhP 20,000). The costs of 
US$600 (PhP 30,000) for a 2004 case and US$1,000 (PhP 50,000) for a 1996 case appeared to be 
outliers.  All cases between 2002 and 2007 averaged US$234.80 (PhP 11,740) with a standard deviation 
of US$137.20 (PhP 6,860). For the more recent cases in 2006 (12 cases) and 2007 (1 case), the average 






Table 2. Dengue knowledge and preventive practices 
A. Questionnaire statements to test the respondents’                




1. Dengue fever is caused by mosquitoes that bite during the daytime. 89 
2. The dengue virus is also transmitted by cockroaches. 97 
3. Children are more prone to contracting dengue fever.  87 
4. Every person with dengue fever requires blood transfusion. 74 
5. A surviving dengue victim acquires lifetime immunity to the dengue 
virus. 
88 
6. Dengue mosquitoes breed and lay their eggs only in dirty waters. 58 
7. A person sick with dengue is contagious to other people. 89 
8. Putting salt in household containers that inherently and regularly 
accumulate water such as ant traps and refrigerator water trays can 
prevent mosquito breeding.   
28 
B. Questionnaire statements to determine the preventive            





1. We regularly clean and scrub water containers inside our house such 
as flower vases, ant traps, water trays of refrigerators, and bottom saucers 
of ornamental plants. 
96 
2. We regularly clean our roof gutters of debris to prevent accumulation 
of water. 
47 
3. We cover our water storage containers. 96 
4. I buy insect repellant lotion for my children to prevent them from 
contracting dengue fever.  
58 
5. I don’t allow my children to play outside the house during the rainy 
season to prevent them from contracting dengue fever. 
75 
6. We use bednets when sleeping. 12 
7. We treat our curtains and mosquito bednets with chemicals 
(pyrethoids) to make them toxic resting places for mosquitoes. 
56 
Note: The percentage (%) figures in sections A and B of the table refer respectively to the proportions of 
respondents who answered the dengue information questions correctly, and who undertook dengue 
prevention practices. Questionnaire statements required AGREE/DISAGREE responses.  
 
3.1.3 House ownership, sanitation and health 
Table 3 summarizes the house ownership, sanitation and health conditions of the 
sample group. Only a fourth of the respondent households owned their houses. The 







houses owned by relatives. The majority of the households used water-sealed toilets 
without flush. Slightly less than half of the households used water-sealed toilets with 
flush. Only a few households had no toilet in their homes. About two-thirds of the 
households had private connection with either of the two water concessionaires in 
Metro Manila. The remaining one-third had shared connection.  
The majority of the households reported only occasional (“sometimes”) or rare 
incidence of fever among their members, i.e., just about 1-3 times a year. Very few had 
frequent occurences of fever (i.e., once a month). High blood pressure and asthma were 
the most common diseases in the households surveyed. Diabetes ranked third, followed 
by heart disease. 
 
Table 3. House ownership, sanitation and health 
Variables Proportion (%) of households 
House ownership 
     Own house 
     Renting 
     Owned by relatives 
     Provided by employer 
 
25 (33,220/660,982)* 
36 (75/3,730)**  
39 
0 
Type of toilet 
    Water-sealed toilet with flush 
    Water-sealed toilet without flush 
    Public/communal toilet 
    Open pit 







Main water source 
    MWSS private connection 
    MWSS shared connection 
    Own well 
    Public (communal) well 
    Public communal tap 
    Water vendor 









Frequency of fever in the household 
    Frequent (not less than once a month) 
    Not so frequent (once in 2-3 months/4-6 times a year) 
    Sometimes (once in 4-11 months/2-3 times a year)  






Illnesses in the household 
    Heart disease 
    High blood pressure 
    Asthma 
    Diabetes 
    Liver disease 
    Cancer 










* = average value of owned houses (US$/PhP) 








The survey results confirmed the widespread acceptance of vaccination and the 
availability of public vaccination programs in the Philippines.  Almost all the 
respondents from low to high income classes had the children in their households given 
the basic vaccines as provided in the government’s Expanded Program on 
Immunization6 (See Table 4). The majority of the households availed themselves of the 
free vaccination services provided by the government and charitable institutions.  
 
Table 4. Vaccinations for children 
Vaccinations and Providers Proportion (%) of 
respondents  
Children vaccinated for: 
  Tuberculosis (BCG) 99 
  Diphtheria-Pertussis-Tetanus (DPT) 99 
  Oral Polio Vaccine (OPV) 98 
  Measles 95 
  Hepatitis B 94 
Vaccinations taken at:* 
   Private clinics/hospitals 41 
   Public clinics/hospitals (free) 9 
   Free vaccination programs of charitable organizations  66 
Note: * = Sum exceeds 100% as respondents were allowed to give multiple answers. 
 
3.2 WTP and VSL 
Most respondents accepted the dengue vaccine scenario. Only three of the 500 
respondents rejected our description of the dengue vaccine as a safe and effective means 
of eliminating the chance of contracting dengue and thus of reducing mortality risks. 7 
These three indicated they would not buy any vaccine and would not take the vaccine 
even if it were offered for free.  
                                                 
6 The Expanded Program on Immunization is a priority program of the Department of Health which 
primarily aims to give all children the following basic vaccines before their first birthday: Bacillus 
Calmette Guerin (BCG) for tuberculosis, measles, three doses each of Diphtheria-Pertussis-Tetanus 
(DPT), and the Oral Polio Vaccine (OPV). 
7  One thought that he and his family members had a very small chance of getting ill with dengue. The 
second likewise believed that his household had a small chance of contracting dengue and further 
suspected the effectiveness of the vaccine and the side effects it might cause. The third also questioned 








Two hundred and seventy-one respondents indicated their willingnesss to buy 
one or more dengue vaccines for their household members. Table 5 shows the 
proportion of household members, by age group, for whom a dengue vaccine would be 
purchased. Two observations can be made. One, the proportion of household members 
for whom a vaccine would be purchased generally declined with higher vaccine price 
for both the 14 years and below age group and 15 years and above age group. Thus, we 
have a fairly well-behaved bid function for both age groups. Two, the proportion of 
household members for whom a vaccine would be purchased was remarkably higher for 
the younger group at all bid levels and for both vaccine durations. This could indicate 
that the respondents factored the higher mortality risk from dengue of the younger age 
group into their WTP decisions. 
There were 34 (out of 271)  who were not so sure or not sure about buying the 
vaccine. Figures enclosed in parenthesis in Table 5 give the proportions of household 
members for whom a dengue vaccine would be purchased when unsure “buy” answers 
were considered “not buy” answers. The two observations above, however, hold for this 
data set as well.  
 





1-year efficacy vaccine 10-year efficacy vaccine 
14 yrs & below 15 yrs & above 14 yrs & below 15 yrs & above 
2 0.625 (0.612)  0.196 (0.196) 0.689 (0.641) 0.244 (0.237) 
10 0.621 (0.534)   0.112 (0.033) 0.656 (0.613) 0.094 (0.094) 
20 0.304 (0.250) 0.055 (0.031) 0.505 (0.362) 0.127 (0.076) 
60 0.298 (0.234) 0.015 (0.015) 0.400 (0.358) 0.078 (0.054) 
100 0.231 (0.212) 0.047 (0.020) 0.234 (0.181) 0.044 (0.044) 
Note: * = Figures in parenthesis correspond to the proportions when unsure “buy” answers are converted 
to “not buy” answers. 
 
Buying respondents (both sure and not sure) were also asked to indicate which 
expenditure item they would reduce the most to free resources to buy the vaccine. The 
answers are summarized in Table 6. The biggest proportion of respondents selected 
savings, followed by clothing, and then recreation. Other items/resources specified by 






Table 6. Expenditures to be reduced most to buy the dengue vaccine 
Expenditure item No. of respondents Proportion (%) of buying 
respondents 
Food 9 3.3 
Clothing 91 33.6 
Recreation 46 17.0 
Savings 96 35.4 
Others 29 10.7 
Buying respondents 271 100.0 
 
 The answers to the debriefing questions indicated that generally, the 
respondents  seriously considered their budget constraints and  gave thoughtful answers. 
They also reflected the efforts of the enumerators to elicit honest responses from the 
respondents. The hypothetical CV scenario was expected to generate a number of 
unsure answers and this came out clearly in the survey.   
 
3.2.1 Household vaccine demand model 
Figure 1 shows the proportion of all household members for whom vaccines 
would be purchased.  The bid function is well-behaved for both vaccine durations. The 
proportion of household members for whom vaccines would be purchased 
monotonically declined as the vaccine price increased. 
 
 




































Household vaccine demand, expressed in terms of the number of vaccines the 
repondent would purchase for household members in proportion to the total number of 
household members, was estimated for each vaccine duration as a linear function of 
household income, other household characteristics, and respondent’s characteristics 
using ordinary least squares. 
The results of the regression runs are summarized in Table 7. Our household 
vaccine demand model revealed a significant positive income effect.  Two dengue-
related household profile variables, namely DengueFamily and Prevent, yielded some 
siginificant effects on vaccine demand which were in accord with expectations, i.e., 
households with a past case/s of dengue and which undertook more of the dengue 
preventive measures cited were likely to buy more vaccines. The respondent’s 
characteristics (i.e., gender, age, and smoking) and knowledge about dengue did not 
yield any consistent nor significant influence on vaccine demand.  Dummy variables for 
the survey sites generally had a negative sign, albeit with varying degrees of 
significance, indicating that the demand for dengue vaccines was higher for households 
in Quezon City (the omitted survey site) than in Pasig, Manila, Caloocan and Makati. 
This could be due to the relatively higher incidence of dengue in Quezon City. 
 
Table 7.  Household vaccine demand (as a proportion of household size), Ordinary 
Least Squares 




Constant 0.332** 0.150 
Income 0.004*** 0.004*** 
RespondentGender -0.046 0.049 
RespondentAge -0.004 -0.001 
RespondentSmoking 0.070* 0.000 
DengueFamily 0.154** 0.114 
DengueOthers 0.000 -0.000 
Correct -0.006 -0.008 
Prevent 0.014 0.027* 
FeverFrequency -0.020 0.000 
Pasig -0.127** 0.000 
Manila 0.010 -0.047 
Caloocan -0.014 -0.104* 
Makati -0.079 -0.097 
R-square 0.170 0.140 
Number of observations 250 250 






3.2.2 The vaccine purchase decision for individual child household 
members 
Table 8 presents the results of the binary probit random effects model of the 
respondents’ stated decisions to purchase a dengue vaccine for each household member 
aged 14 years and below. Results for both the one-year and ten-year duration vaccines 
conformed with economic theory and intuition in that the vaccine price had a signifcant 
negative effect on the respondent’s decision to purchase a vaccine for a household 
member while the predicted vaccine demand had a significant positive effect. The 
probability of the respondent buying a vaccine for a member was also significantly 
higher for younger members and for members who were the respondent’s own children. 
The gender of the household member had no systematic and significant effect on the 
decision to buy the vaccine.  
 
Table 8. Willingness to pay for a dengue vaccine for household members aged 14 years 
and below, Binary probit model with unbalanced panel random effects  




Constant -8.434* -13.676** 
Vaccine price -0.0021*** -0.0027** 
Predicted vaccine demand (in proportion 
to household size) 
36.076*** 53.363** 
Member age -0.319*** -0.579** 
Member gender 0.068 -0.646 
Member is respondent’s child 6.648 9.862** 
Random effects 0.973*** 0.983*** 
Log-likelihood  -181.688 -159.864 
Number of observations 521 479 
Notes: * = significant at α = 0.10; ** = significant at α = 0.05; *** = significant at α = 0.01 
 
Using the results of the random effects probit model, the mean willingness to 
pay for a dengue vaccine for children 14 years old and younger was calculated to be 
about US$35 (PhP 1,729) for the one-year duration vaccine and US$41 (PhP 2,047) for 
the ten-year duration vaccine (first panel of Table 9).   
The non-parametric mean willingness to pay values for the dengue vaccine 
calculated using the Turnbull method are shown in the second panel of Table 9. The 
non-parametric WTP  values were slightly lower than the parametric estimates for both 









Table 9. Mean WTP for a dengue vaccine for children aged 14 years and below 
 1-year efficacy vaccine 10-year efficacy vaccine 
Parametric   
   US$ (PhP)  34.57 (1,729)  40.95 (2,047)  
Non-parametric                
(lower-bound estimates) 
  
   US$ (PhP)   30.4 (1,520)  37.0 (1,852)  
 
The mean WTP for the ten-year duration vaccine was only slightly higher than 
the mean WTP for the one-year duration vaccine, and the difference was much smaller 
than the proportionality requirement of the external scope test. Nearly all previous 
studies of mortality risk reduction failed the external scope test. From among 25 CVM-
VSL studies reviewed by Hammitt and Graham (1999), only nine allowed for an 
external magnitude test and all nine studies violated the proportionality assumption.8 
More recent CVM-VSL studies employing visual aids and risk comprehension training 
modules were no exception (see, for instance, Hammitt and Liu 2004; Alberini, Hunt 
and Markandya 2004; Liu et al  2005; Maskery et al 2007).     
 
3.2.3 VSL 
Reflecting the high literacy rate in the Philippines, particularly in highly 
urbanized MM, respondents generally understood the concept of mortality risk.  More 
than four-fifths of the respondents correctly answered the comprehension test question 
in the short module on understanding mortality risks after only one explanation. About 
16% required one repetition of the explanation while the remaining 3% required two 
repetitions. Thus, we feel reasonably confident that respondents understood and took 
into consideration the mortality risk reduction that the dengue vaccine would bring 
about. 
The results of the debriefing questions on the relative importance of the different 
reasons for buying the dengue vaccine for young members of the household aged 14 
years and below are summarized in Table 10. On average, “yes” respondents gave the 
mortality risk reduction effect of the vaccine a weight of 38.7% (or a 95% confidence 
interval of 35.7–41.7%). This result indicates that although the mortality risk reduction 
was  considered the most important among the five reasons given for buying the dengue 
vaccine, the weight attached to it was much lower (less than half) than the 100% weight 
implicitly assumed in VSL studies that based their estimates on the entire willingness to 
pay for an intervention.  
 
                                                 







Table 10. Relative importance of reasons for buying the dengue vaccine 
 Mean Std. Deviation 
1. To prevent death from dengue 3.87 1.65 
2. To avoid the pain and suffering from being 
ill with dengue 
1.91 1.12 
3. To avoid incurring medical expenses 1.34 1.11 
4. To avoid inconvenience and being absent 
from work or school 
1.58 1.26 
5. So that it will not be necessary for us to take 
and spend on other precautions (such as using 
anti-mosquito lotions, mosquito nets, and 
mosquito killers)  
1.31 1.24 
 
We used the stated weights in Table 10 to break down the willingness to pay for 
a dengue vaccine into the different underlying reasons and isolate the mean value 
attached by the respondents to a reduction in the risk of a child dying in their 
households. Following Hammitt and Liu (2004) and Vassanadumrongdee and Matsuoka 
(2005), the VSL estimates were calculated as the average of the values of the two risk 
reduction magnitudes. The WTP and resulting VSL estimates are shown in Table 11. 
The value of statistical life estimates for a child 14 years old or younger in Metro 
Manila ranged from US$0.70 million to US$0.80 million, about 118-133 times the 
annual income. Our results are fairly within the range of estimates derived in recent 
survey-based VSL estimates in the region. Vassanadumrongdee and Matsuoka (2005) 
came up with VSL estimates of US$0.7-1.5 million, about 100-170 times the annual 
income, in their study with scenarios on traffic accidents and air pollution in Bangkok in 
2003. Meanwhile, Hammitt and Liu’s (2004) liver cancer and non-cancer diseases 
scenarios  resulted in VSL estimates of US$0.5-1.1 million, 36-80 times the annual 
income in Taiwan in 2001.  
Compared to other VSL estimates for children, our estimates for Metro Manila 
are lower than previous ones in the US using revealed preference averting behavior 
methods (e.g.: Mount et al’s (2001) estimate of  US$2.6-7.7 million based on  vehicle 
fatality rates and costs in 1997, and Jenkins, Owens and Wiggins’ (2001) estimate of 
US$1.1-2.7 million based on bicycle helmet demand in 1997), but much higher than the 
recent child VSL estimate for Bangladesh of US$30-60,000 (Maskery et al 2007). 
Table 11. WTP for mortality risk reduction and VSL estimates for children in                
Metro Manila 
 Parametric Non-parametric 
WTP US$ (PhP) 14.61 (699) 13.04 (652) 
VSL US$ millions (PhP millions) 0.80 (39.9) 0.70 (35.2) 








4.0 CONCLUDING REMARKS  
We arrived at estimates of the value of statistical life of a child in Metro Manila, 
which to our knowledge, are the first VSL estimates for the Philippines and one of the 
very few contingent valuation method (CVM)-based VSL estimates for children. Our 
estimates were derived from the willingness to pay for a hypothetical dengue vaccine—
a familiar risk and intervention context for Filipinos, particularly for children.  
Our study differs from existing literature in two ways. First, the WTP for a 
dengue vaccine was elicited for each and every household member instead of only one 
household member. We believe that our approach better reflects the reality of household 
decision-making wherein the head decides to purchase an individually consumed good 
for one or several household members after considering the needs and wants of all 
members in relation to the single household budget constraint.  Likewise, a different 
modeling procedure was undertaken. We used a two-stage model where the household 
vaccine demand, in proportion to household size, was regressed with household income 
and a vector of respondent and other household characteristics in the first stage, and the 
“yes-no” response to the dichotomous choice WTP question for each household 
member was specified as a random effects probit function of the predicted household 
vaccine demand  (derived from the first stage) and a vector of particular household 
member characteristics in the second stage.  
Second, the WTP for the mortality risk reduction was isolated from the stated 
WTP for the specific health intervention before VSL calculation. We found out that 
although the mean weight for the mortality risk reduction was larger than the weights 
for the other reasons for buying the vaccine, it was only about a third of the total.  This 
result suggests the extent of likely deviations of past specific intervention-based VSL 
estimates when applied to other risk contexts—a finding which is not inconsistent with 
studies recommending risk context adjustment factors of as large as two to four times 
for VSL estimates (Revesz 1999; Hammitt and Liu 2004).  
 Our models conformed with predictions of economic theory—our household 
vaccine demand model yielded a significant positive income effect while our random 
effects probit model for vaccine purchase decisions yielded a significant negative price 
effect.  Our VSL estimates compared well with CVM-VSL estimates in existing 
literature—relatively lower than those derived for developed countries and falling in the 
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